Menu
  • Join
  • Login
  • Contact
 

Search abstracts


Current status & prospect of evaluation and approval for hebral medicine in korea

  • At: 2008 FIP Congress in Basel (Switzerland)
  • Type: Poster
  • By: CHO, Changhee (Korea Food and Drug Administration, Seoul, South-Korea)
  • Co-author(s): OH, Mihyune (Korea Food and Drug Administration, SEOUL, South-Korea)
    LEE, Jongpill (Korea Food and Drug Administration, SEOUL, South-Korea)
    BAEK, Juhyun (Korea Food and Drug Administration, SEOUL, South-Korea)
    KIM, Koeun (Korea Food and Drug Administration, SEOUL, South-Korea)
    Do, Wonim (Korea Food and Drug Administration, SEOUL, South-Korea)
    AHN, Jaehyung (Korea Food and Drug Administration, SEOUL, South-Korea)
    HWANG, Jisang (Korea Food and Drug Administration, SEOUL, South-Korea)
    CHO, Junghee (Korea Food and Drug Administration, SEOUL, South-Korea)
  • Abstract:

    Recently, the World Health Organization estimated that 80 % of people worldwide rely on herbal medicines for some aspect of their primary healthcare. In Korea, We review the efficacy and safety of natural new drugs, herbal medicinal products according to Regulation of the Efficacy and Safety Evaluation of Drugs, etc at KFDA. Herbal medicinal..

  • The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 4 October 2019

FIP Congresses